Evidence map›Paper›PMID 42652042›Full record

ArticleBiomedicines2026

Temporal Dynamics of PD-L1 Surface in RKO Cells: Characterizing the Reversible Impact of the Small-Molecule Dimerizer BMS-202.

Gohar Sevoyan, Daniel Polianczyk, Siranuysh Grabska, Hovakim Grabski, Ruben Abagyan, Zaruhi Karabekian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gohar SevoyanL.A. Orbeli Institute of Physiology, National Academy of Sciences, Yerevan 0028, Armenia.ORCID 0000-0002-3446-6314
Daniel PolianczykL.A. Orbeli Institute of Physiology, National Academy of Sciences, Yerevan 0028, Armenia.ORCID 0000-0002-1391-742X
Siranuysh GrabskaL.A. Orbeli Institute of Physiology, National Academy of Sciences, Yerevan 0028, Armenia.ORCID 0000-0001-9291-3357
Hovakim GrabskiL.A. Orbeli Institute of Physiology, National Academy of Sciences, Yerevan 0028, Armenia.ORCID 0000-0001-6115-9339
Ruben AbagyanSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, San Diego, CA 92093-0657, USA.ORCID 0000-0001-9309-2976
Zaruhi KarabekianL.A. Orbeli Institute of Physiology, National Academy of Sciences, Yerevan 0028, Armenia.ORCID 0000-0002-8693-7288

Funding

Science Committee of MESCS RA № 25FAST-1F002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

assaycancerimmune checkpoint inhibitorsimmune system

Identifiers

PMID42652042
PMCPMC13510185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.